briakinumab

B3R1I1A1K5I1N1U1M3A1B3

noun

A human monoclonal antibody being developed to treat rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis.

Scrabble 21

Meanings

nounbriakinumab (uncountable)
  1. uncountablemedicineA human monoclonal antibody being developed to treat rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis.

    As another interleukin 12/23 antagonist, briakinumab, was withdrawn from further development in part due to concerns about cardiovascular safety, discussion has also emerged on cardiovascular safety of ustekinumab.

    2015 December 4, “Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients”, in PLOS ONE, →DOI

Origin

From -kin- (“interleukin”) + -umab (“human monoclonal antibody”).

Full word history & related roots →
Cite this entry
APA

briakinumab. (n.d.). In WatkinsX Dictionary. Retrieved November 4, 2026, from https://dictionary.watkinsx.com/word/briakinumab

MLA

“briakinumab.” WatkinsX Dictionary, https://dictionary.watkinsx.com/word/briakinumab. Accessed November 4, 2026.

Chicago

WatkinsX Dictionary, s.v. “briakinumab,” accessed November 4, 2026, https://dictionary.watkinsx.com/word/briakinumab.

Source: briakinumab on Wiktionary, CC BY-SA 4.0.